跳至主要内容
临床试验/NCT02648971
NCT02648971终止不适用

A Randomized Controlled Trial to Compare Single Portal Versus Two Portal Knee Arthroscopy Techniques in Patients With Meniscal Injuries and Articular Cartilage Pathology

Wake Forest University Health Sciences2 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2016年1月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
36
试验地点
2
主要终点
IKDC Score

研究概览

简要总结

This randomized, controlled clinical trial will compare the outcomes of single portal versus two portal techniques in patients who have meniscus or articular cartilage pathology. The study hypothesis is that patients who undergo single portal arthroscopy will have less pain post-operatively, use less pain medication, and have a higher International Knee Documentation Committee (IKDC) score at six months and one year compared to patients who undergo traditional two portal knee arthroscopy.

详细描述

Background, Rationale and Context

Knee arthroscopy procedures provide a minimally invasive method to assess the status of the knee joint in order to repair injuries of the meniscus and articular cartilage. In the past, two or more small openings in the skin (portals) were required in order to allow the passage of both an arthroscope to provide visualization of the knee joint and the instrument used to complete the surgical repair process. However, recent innovations in arthroscopy instrumentation have resulted in the ability to use one portal for knee arthroscopy procedures with both the arthroscope and the instruments passed into the knee joint through the same portal. Both uniportal and two portal arthroscopic techniques are used currently for knee arthroscopy procedures in the Department of Orthopaedic Surgery at Wake Forest Baptist Health.

Objectives

This randomized, controlled clinical trial will compare the outcomes of single portal versus two portal techniques in patients who have meniscus or articular cartilage pathology. The study hypothesis is that patients who undergo single portal arthroscopy will have less pain post-operatively, use less pain medication, and have a higher International Knee Documentation Committee (IKDC) score at six months and one year compared to patients who undergo traditional two portal knee arthroscopy.

Methods and Measures

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
21 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men and women between 21 and 65 years of age, who agree to comply with the protocol
  • Patients undergoing a primary knee arthroscopy procedure for meniscus or articular cartilage pathology

排除标准

  • Patients with a history of long term pain medication use and/or chronic pain conditions unrelated to the surgery.
  • Subjects with severe renal disease, allergies to pain medication, and subjects that will have adverse drug-drug reactions from prescribed pain medication.
  • Patients with previous reconstructive procedures, lateral retinacular release, or microfracture
  • Active knee infection or sepsis at the time of surgery
  • Meniscal injuries requiring repair
  • Ligamentous instability
  • Advanced degenerative or inflammatory arthritis
  • Known cancer at the time of surgery
  • Conditions that might interfere with recovery from knee arthroscopy (i.e. conditions or diseases of the nervous and/or muscular system, vascular disease, uncontrolled diabetes)
  • Malignant tumor history or treatment of malignant tumor of the knee
  • Lower extremity condition causing abnormal ambulation (e.g. ankle fusion, ankle arthroplasty, previous hip fracture, knee arthrofibrosis)
  • Pregnant, breast feeding, or planning on becoming pregnant during the time frame of the study, (if a woman of child-bearing age)
  • Emotional or neurological conditions that affect the subject's ability or willingness to participate in the study including mental illness or drug and/or alcohol abuse
  • Severely overweight (BMI >40) at study enrollment or surgery
  • Currently participating in another research study
  • Prisoner or impending imprisonment
  • Workers' Compensation claims

结局指标

主要结局

IKDC Score

时间窗: 12 Months

IKDC subjective knee evaluation form scores range from 0 points (lowest level of function or highest level of symptoms) to 100 points (highest level of function and lowest level of symptoms).

IKDC (International Knee Documentation Committee) Score

时间窗: Baseline

IKDC subjective knee evaluation form scores range from 0 points (lowest level of function or highest level of symptoms) to 100 points (highest level of function and lowest level of symptoms).

次要结局

  • Number of Participants That Required the Use of Narcotics(Days 1 and 4)
  • Pain Levels(Days 1 and 4)
  • Number of Participants That Required the Use of Pain Medication(Days 1 and 4)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验